InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-13.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Quinn Katherine B, Vice-Présidente et Administratrice. Officer active across 3 companies, notably US Bancorp \de\. Aggregated, 15 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €2.5m. Activity tracked since 18 May 2021. The latest transaction was filed on 7 February 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations15 total
3,279.254 shares@ US$57.9453.0% of flowClass A Common StockSEC:0000100493-25-000034:0
3,328.262 shares@ US$52.5847.0% of flowClass A Common StockSEC:0000100493-24-000040:0
2,502 shares@ US$47.113.3% of flowCommon Stock, $0.01 par valueSEC:0001225208-23-003531:0
21,594 shares0Common Stock, $0.01 par valueSEC:0001225208-23-003463:0
26,156 shares0Common Stock, $0.01 par valueSEC:0001225208-23-001759:0
21,505 shares0Common StockSEC:0001209191-22-043528:0
2,572 shares@ US$55.254.0% of flowCommon Stock, $0.01 par valueSEC:0001225208-22-004365:0
17,048 shares0Common Stock, $0.01 par valueSEC:0001225208-22-004297:0
11,435 shares@ US$58.5518.2% of flowCommon Stock, $0.01 par valueSEC:0001225208-22-002296:0
24,313 shares0Common Stock, $0.01 par valueSEC:0001225208-22-002030:0
10,617 shares0Common StockSEC:0001209191-21-046132
10,617 shares0Common StockSEC:0001209191-21-046132:0
25,000 shares@ US$61.4738.9% of flowCommon Stock, $0.01 par valueSEC:0001225208-21-008308
25,000 shares@ US$61.4738.9% of flowCommon Stock, $0.01 par valueSEC:0001225208-21-008308:0
544 sharesCommon Stock, $0.01 par valueSEC:0001225208-16-024828:0
15 of 15 declarations
About Quinn Katherine B
Katherine B. Quinn is the Vice Chair and Director at US BANCORP \DE\ and RITE AID CORP. She plays a key role in governance and strategy for both companies. Katherine brings valuable expertise in the financial and healthcare sectors, enabling her to contribute to informed strategic decisions. Her commitment to innovation and growth is essential for both organizations.
